Company Data
Curis Inc.
Ticker
CRIS
Current Price
$3.1
Market Cap
$26.2M
Price Target
Refer to Report
Volume
19.3K
52wk Range
$2.86 - $17.49
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.